-
Something wrong with this record ?
Očekávání osobního přínosu subjektu z účasti v klinickém hodnocení
Olga Norková
Language Czech Country Czech Republic Media elektronický zdroj
Digital library NLK
Full text - Article
Issue
Volume
Source
Source
NLK
ROAD: Directory of Open Access Scholarly Resources
from 2011
- MeSH
- Altruism MeSH
- Human Experimentation ethics standards legislation & jurisprudence MeSH
- Controlled Clinical Trials as Topic methods standards utilization MeSH
- Pharmaceutical Preparations MeSH
- Ethics, Medical MeSH
- Humans MeSH
- Motivation MeSH
- Reward MeSH
- Drug Approval MeSH
- Patient Satisfaction MeSH
- Researcher-Subject Relations ethics MeSH
- Check Tag
- Humans MeSH
Participation of Human Subjects in a Clinical Trial is the fundamental part of Medical Research. Human Subject's participation depends on the willingness of the potential Subjects to volunteer in such a Clinical Trial. The Subject's motivations for the Clinical Trial participation diverse based on the different motivational factors. Patient's deciding whether to participate in a Clinical trial or not is influenced mainly by the current Patient’s health status and the possibility of the available standard therapy in the treatment of a serious or a life-threatening illness. The important role in the Patient decision process takes the close relationship Physician-Patient. There is no consensus among Scientists whether the Patient’s expected therapeutic benefit using the new medicinal product is the most motivational factor for the Clinical trial participation or not. Some of the latter research has concluded that some Patients frequently overestimate the chance of benefit from particular treatment. However the Patient's expectations of the potential therapeutic benefit do not depend on the Patient's correct understandings of the Clinical Trial purpose. The Patient’s willingness to contribute to the progress of medicine and desire to help other Patients is secondary consideration for the Clinical Trial participation which is reported in the medical journals. Especially Patients suffering from a life-threatening illness report altruistic reasons however this will not exclude them to expect the potential personal benefit as well. The indirect costs reimbursement to Patients during the Clinical Trial participation might motivate many potential participants for the Clinical Trial participation. This article sought to present the most frequent Subject's Expected Benefit from the Clinical Trial participation in the context of the Patient being engaged in Medical Research. Gaining a deeper understanding of this topic might be benefited for both Researchers and Physicians.
Očekávání osobního přínosu subjektu z účasti v klinickém hodnocení [elektronický zdroj] /
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12014880
- 003
- CZ-PrNML
- 005
- 20120807165338.0
- 007
- cr|cn|
- 008
- 120509s2012 xr fs 000 0cze||
- 009
- eAR
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a cze $b eng
- 044 __
- $a xr
- 100 1_
- $a Norková, Olga. $7 _AN067573 $u Fakulta humanitních studií Univerzity Karlovy
- 245 10
- $a Očekávání osobního přínosu subjektu z účasti v klinickém hodnocení $h [elektronický zdroj] / $c Olga Norková
- 504 __
- $a Literatura $b 18
- 520 9_
- $a Participation of Human Subjects in a Clinical Trial is the fundamental part of Medical Research. Human Subject's participation depends on the willingness of the potential Subjects to volunteer in such a Clinical Trial. The Subject's motivations for the Clinical Trial participation diverse based on the different motivational factors. Patient's deciding whether to participate in a Clinical trial or not is influenced mainly by the current Patient’s health status and the possibility of the available standard therapy in the treatment of a serious or a life-threatening illness. The important role in the Patient decision process takes the close relationship Physician-Patient. There is no consensus among Scientists whether the Patient’s expected therapeutic benefit using the new medicinal product is the most motivational factor for the Clinical trial participation or not. Some of the latter research has concluded that some Patients frequently overestimate the chance of benefit from particular treatment. However the Patient's expectations of the potential therapeutic benefit do not depend on the Patient's correct understandings of the Clinical Trial purpose. The Patient’s willingness to contribute to the progress of medicine and desire to help other Patients is secondary consideration for the Clinical Trial participation which is reported in the medical journals. Especially Patients suffering from a life-threatening illness report altruistic reasons however this will not exclude them to expect the potential personal benefit as well. The indirect costs reimbursement to Patients during the Clinical Trial participation might motivate many potential participants for the Clinical Trial participation. This article sought to present the most frequent Subject's Expected Benefit from the Clinical Trial participation in the context of the Patient being engaged in Medical Research. Gaining a deeper understanding of this topic might be benefited for both Researchers and Physicians.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a léčivé přípravky $7 D004364
- 650 _2
- $a schvalování léčiv $7 D017277
- 650 _2
- $a klinické zkoušky kontrolované jako téma $x metody $x normy $x využití $7 D018849
- 650 _2
- $a experimenty na lidech $x etika $x normy $x zákonodárství a právo $7 D006805
- 650 _2
- $a vztahy mezi výzkumníkem a subjektem $x etika $7 D035844
- 650 _2
- $a spokojenost pacientů $7 D017060
- 650 _2
- $a lékařská etika $7 D004992
- 650 _2
- $a altruismus $7 D000533
- 650 _2
- $a motivace $7 D009042
- 650 _2
- $a odměna $7 D012201
- 773 0_
- $t Časopis zdravotnického práva a bioetiky $x 1804-8137 $g Roč. 2, č. 1 (2012), s. 34-45 $w MED00175105
- 856 41
- $u http://medlawjournal.ilaw.cas.cz/index.php/medlawjournal/article/view/22/28 $y plný text volně přístupný
- 910 __
- $a ABA008 $b online $c 935 $y 2
- 990 __
- $a 20120509123426 $b ABA008
- 991 __
- $a 20120807165727 $b ABA008
- 999 __
- $a ok $b bmc $g 908539 $s 771946
- BAS __
- $a 3 $a 4
- BMC __
- $a 2012 $b 2 $c 1 $d 34-45 $i 1804-8137 $m Časopis zdravotnického práva a bioetiky $n Čas. zdr. práva bioet. $x MED00175105
- LZP __
- $a 2012-23/dkjb